The Strategic Alliances team at NCATS helps industry and academia interact and partner with NCATS laboratories and scientists. Learn more.
-
Research
-
- Funding & Notices
- News & Media
- About Translation
-
- About NCATS
-
NCATS Programs & Initiatives
- 3-D Tissue Bioprinting Program
- Assay Development and Screening Technology (ADST)
- Biomedical Data Translator
- Bridging Interventional Development Gaps (BrIDGs)
- Chemistry Technology
- Discovering New Therapeutic Uses for Existing Molecules
- Genetic and Rare Diseases Information Center (GARD)
- Matrix Combination Screening
- Early Translation Branch (ETB)
- A Specialized Platform for Innovative Research Exploration (ASPIRE)
- About NCATS
Strategic Alliances
Tissue Chips Orbit Earth for Disease AnswersTissue chip experiments aboard the International Space Station could advance the science of preventing osteoarthritis, resisting muscle wasting and reversing heart tissue damage on Earth.
A new digital book showcases 22 patents issued to NCATS and its collaborators that can help speed the process of translating discoveries into medical interventions. NCATS seeks additional commercial partners to license and use the patents.
NCATS is speeding the formation of innovative private-public partnerships through the use of standardized legal agreements.
Work with Strategic AlliancesContact us to find out how NCATS can collaborate with your organization.
Contact us to find out how NCATS can collaborate with your organization.
Work with US
NCATS staff are available to discuss ideas for collaborations and partnerships to improve translational research.
Licensing Opportunities
Inventions made by NCATS employees are owned by the federal government. Patenting and licensing are used to help ensure the technology is fully developed, commercialized and advancing public health. See all NCATS licensing opportunities.
Subscribe for Updates
Sign up to receive news and funding announcements from NCATS.
- Funding & Notices
-